Local intra-articular injection of anesthetics (LIA) is increasingly used during knee arthroscopy for pain relief. The LIA can only be performed at the end of surgery as the knee joint is continuously flushed during the arthroscopy. As a consequence, an optimal analgesic effect is only obtained one hour after surgery and opiates are typically used as pain relief in the immediate postoperative period. Since these opiates have a number of side effects such as nausea, vomiting and drowsiness, other analgetic methods are desirable. Intravenous administration of lidocaine, a safe, inexpensive analgesic, is already used in major (abdominal) surgeries and might also be a promising method for pain relief in the first hour after knee arthroscopy, in anticipation of the onset of the analgesic effect of the LIA. The aim of this study is to verify if systemic administration of lidocaine has a beneficial effect on the pain immediately after knee arthroscopy. In addition, the effect of systemic lidocaine administration on postoperative nausea, vomiting and general patient comfort will be evaluated.
2X30 patients which are planned for elective knee arthroscopy are randomised: Lidocaine-group and Placebo-group. All patients receive standardised multimodal intravenous analgesia. After standardised induction of anesthesia, patient positioning and administration of basic analgetics paracetamol \& diclofenac, the patient is administered either linisol 2% (1.5 mg/kg) or placebo NaCl 0.9% (0.075 ml/kg = equivalent volume). At the end of the procedure, linisol or placebo is readministered at the same dose. The surgeon and anesthesiologist are blinded for patient allocation. Postoperative analgesic consumption, nausea and vomiting (PONV), general comfort and pain scores are recorded. Visual Analogue scores (VAS) for knee pain are assessed before surgery, 1-15 minutes after awakening, at the moment of discharge from the post-anesthesia care unit (PACU) and at hospital discharge.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Enrollment
60
Systemic lidocaine is administrated at induction of anesthesia and at the end of surgery (1.5 mg/kg).
Placebo is administrated at induction of anesthesia and at the end of surgery (0.075 ml/kg)
AZ Maria Middelares
Ghent, Oost, Belgium
Visual Analog Score for pain
Pain intensity using the VAS, where 0 = no pain and 100 = pain as bad as can be) before surgery, 1-15 minutes after awakening, at discharge from the PACU and from the hospital
Time frame: from moment of surgery until hospital discharge. on average 8 hours after surgery
incidence of Nausea and vomiting
Incidence of postoperative nausea and vomiting
Time frame: from moment of surgery until hospital discharge. on average 8 hours after surgery
PONV treatment
Number of pharmacological treatments for Postoperative Nausea \& Vomiting (PONV)
Time frame: from moment of surgery until hospital discharge. on average 8 hours after surgery
opioid use
dosing and frequency of opioid use
Time frame: at the PACU on average 60 minutes
length of stay at the PACU
Time (in minutes) between the end of surgery and the discharge from the PACU
Time frame: from moment of surgery until discharge from the PACU. on average 60 minutes after surgery
general patient comfort
VAS for general comfort : from 0 until 100 (0= extremely dissatisfied ; 100= extremely satisfied.
Time frame: at the moment before of hospital discharge. on average 8 hours after surgery.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.